|
|
慢性高原病红细胞寿命测定的研究进展
|
Abstract:
慢性高原病：是高原地区比较常见的一种慢性高原病，严重危害着高原人群的身心健康。近年来，国内外许多学者对高原红细胞增多症发病机制做了较多的研究，但红细胞增多的机制是红细胞过度增殖还是凋亡减少，哪个发挥重要的作用目前还存在争议，两者之间是否存在差异性，故检测其红细胞寿命及相关检验指标，研究红细胞寿命在临床的意义。
Chronic mountain sickness: it is a common chronic mountain sickness in plateau area, which seri-ously harms the physical and mental health of plateau people. In recent years, many scholars at home and abroad on the plateau have done more research on the pathogenesis of the disease of growth in quantity of red blood cells. However, whether the mechanism of erythrocythemia plays an important role is still controversial, and whether there is a difference between the two. Therefore, the red blood cell survival and related test indicators were tested to study the clinical significance of red blood cell survival.
| [1] | León-Velarde, F., et al. (2005) Consensus Statement on Chronic and Subacute High Altitude Diseases. High Altitude Medicine & Biology, 6, 147-157. https://doi.org/10.1089/ham.2005.6.147 |
| [2] | 张寒, 等. 高原人群慢性高原病相关分子机制研究进展[J]. 中国临床新医学, 2020, 13(11): 1165-1170. |
| [3] | 马轶, 罗伟. 慢性高原病的最新治疗研究进展[J]. 中西医结合心血管病电子杂志, 2020, 8(35): 26+46. |
| [4] | 侯云鹏, 等. 慢性高原病诊治研究进展[J]. 人民军医, 2017, 60(12): 1238-1242. |
| [5] | 高文祥, 高钰琪. 慢性高原病分型、诊断与治疗的研究进展[J]. 第三军医大学学报, 2016, 38(5): 431-436. |
| [6] | 郭文静, 等. 模拟高原低氧环境下大鼠性激素水平及红细胞、血红蛋白的变化研究[J]. 西北国防医学杂志, 2016, 37(5): 321-324. |
| [7] | 郝玉姣, 等. 乙酰唑胺治疗慢性高原病的疗效与安全性的Meta分析[J]. 海南医学, 2020, 31(9): 1194-1200. |
| [8] | 谢佳新, 等. 高原驻训人员高原脱适应症发病特征与影响因素调查分析[J]. 西南国防医药, 2021, 31(6): 556-560. |
| [9] | Villafuerte, F.C. and Corante, N. (2016) Chronic Mountain Sickness: Clinical Aspects, Etiology, Management, and Treatment. High Altitude Medicine & Biology, 17, 61-69. https://doi.org/10.1089/ham.2016.0031 |
| [10] | Bai, J., et al. (2015) Incidence and Risk Factors for Myelofi-brotic Transformation among 272 Chinese Patients with JAK2-Mutated Polycythemia Vera. American Journal of Hema-tology, 90, 1116-1121.
https://doi.org/10.1002/ajh.24191 |
| [11] | 解力, 谢慎威. 慢性高原病与高原肺动脉高压在心脏超声、血常规与血生化等指标的差异研究[J]. 西南军医, 2020, 22(4): 322-325. |
| [12] | 张诗璇, 等. 高原红细胞增多症分子机制研究的Meta分析[J]. 重庆医学, 2020, 49(7): 1149-1154+1158. |
| [13] | 吴小东, 杜磊. 高原红细胞增多症[J]. 中国输血杂志, 2013, 26(6): 589-592. |
| [14] | 刘丽军, 等. 高原红细胞增多症的研究进展[J]. 国外医学(医学地理分册), 2018, 39(3): 267-271. |
| [15] | De Maria, R., et al. (1999) Apoptotic Role of Fas/Fas Ligand System in the Regulation of Eryth-ropoiesis. Blood, 93, 796-803. https://doi.org/10.1182/blood.V93.3.796 |
| [16] | 红细胞寿命测定在血液系统疾病中的临床应用中国专家共识[J]. 中华医学杂志, 2019(30): 2321-2324. |
| [17] | Adegoke, S.A., et al. (2016) Electrocardio-graphic Abnormalities and Dyslipidaemic Syndrome in Children with Sickle Cell Anaemia. Cardiovascular Journal of Africa, 27, 16-20. https://doi.org/10.5830/CVJA-2015-059 |
| [18] | Zhang, H.D., et al. (2018) Human Erythrocyte Lifespan Measured by Levitt’s CO Breath Test with Newly Developed Automatic Instrument. Journal of Breath Re-search, 12, Article ID: 036003. https://doi.org/10.1088/1752-7163/aaacf1 |
| [19] | 普布旺堆, 等. 内源性一氧化碳呼气试验检测高原红细胞增多症患者红细胞寿命[J]. 上海医学, 2021, 44(4): 227-230. |
| [20] | 高清妍, 叶蕾, 张凤奎. 红细胞寿命检测的临床应用及意义[J]. 中华血液学杂志, 2019(5): 447-448. |
| [21] | Luo, J.F., et al. (2019) Effect of Hemodialysis on the Red Blood Cell Life Span in Patients with End-Stage Kidney Disease. Therapeutic Apheresis and Dialysis, 23, 336-340. https://doi.org/10.1111/1744-9987.12775 |
| [22] | 梁立莉, 等. 红细胞寿命在肿瘤相关性贫血诊断中的特点及临床应用[J]. 重庆医学, 2022, 51(2): 264-266+270. |
| [23] | 李美健, 等. CO呼气试验方式检测4种常见恶性血液病红细胞寿命长短分析及检测意义[J]. 国际检验医学杂志, 2021, 42(5): 574-578. |
